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Abstract  Hypertension is a global health issue among the adult population. Adherence to antihypertensive medications 
is an effective step for better control of blood pressure and preventing the risk of complications. Several factors support or 
hinder hypertensive patients’ adherence. Objectives: This art icle rev iews the factors affecting adherence to antihypertensive 
treatments, and reflects on these factors from a Saudi Arab ian perspective. Methods: Papers and studies about 
antihypertensive medication adherence were reviewed from different databases including MEDLINE, PubMed, 
ScienceDirect and Google scholar. Results: Factors affecting antihypertensive treatments adherence are classified into three 
domains: Patient (e.g. sociodemographic, individual knowledge and skills), Health System, and Provider related factors.  
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1. Introduction 
Hypertension is defined as raised systolic or diastolic blo
od pressure equal to or more than 160/95 mmHg according to 
the World Health Organisation[1]. Hypertension has become 
a significant health problem in both developing and 
developed countries. Risk factors associated with the 
development of hypertension are family h istory, advanced 
age, gender, a  lack of physical activity, poor diet  (especially 
salty food), overweight and obesity, and increased alcohol 
intake[2-4].  
In 2002, the WHO reported that approximately 20% of the 
world ’s adult population, approximately one billion people, 
are estimated to have hypertension, which contributed to 
more than 7.1 million deaths per year[4]. The report stated 
that the prevalence has dramatically increased in patients 
older than 60 years in a variety of countries, with 50% of 
individuals in this age group having hypertension.  
Hypertension is also a common health problem in Saudi 
Arabia, where the p revalence is increasing. Previous studies 
in Saudi Arabia have estimated the prevalence of 
hypertension at 26.1% among adults aged 30–70 years[5].  
Adherence to antihypertensive medication is an effect ive 
step  fo r con t ro lling  b lood  p ressure and  p revent ing 
comp licat ions . Ho wever,  ce rtain  facto rs  a ffect  a 
hypertensive patient’s behaviour regard ing adherence to 
antihypertensive treatments. These factors can support or  
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hinder adherence behaviour. From the available research in 
the field of hypertension treatment, factors in fluencing 
hypertensive patients’ adherence behaviour to antihypertens
ive medicat ion include patient-related factors (e.g., 
socio-demographic factors and the individual’s knowledge 
and skills), health system-related factors (such as treatment 
cost and patients’ resources), and provider-related factors 
(such as patient-provider relationships and communicat ion).  
Hypertensive patients in Saudi Arabia were reported to 
have low adherence to their antihypertensive treatments. In 
attempting to understand reasons for low adherence, studies 
in Saudi Arab ia have focused on only a single factor. 
Holistically addressing all relevant factors, i.e. those related 
to patients, health systems, and providers, would therefore 
be a significant step in shaping the future of hypertension 
research in Saudi Arabia, and would hopefully point to 
changes and interventions that need to be made to improve 
adherence behaviour among hypertensive patients. 
2. Materials and Methods 
Papers cited in MEDLINE, PubMed, ScienceDirect and 
Google scholar databases were searched using the following 
keywords: Saudi Arabia, hypertension, antihypertensive, 
treatments, adherence and adult. A total of 44 relevant 
articles were found. Articles including information about 
secondary hypertension and children were excluded from 
this review. The init ial focus was on articles that studied 
antihypertensive treatments adherence in relation to 
different factors in the general population. Several studies 
showed the relationship between single factor and 
antihypertensive treatments adherence in adults. The second 
28 Fatmah Alsolami et al.:  Factors Affecting Antihypertensive Treatment Adherence: A Saudi Arabian Perspective   
 
 
step involved searching for papers that focused on factors 
influencing adherence among Saudi Arabian  patients. 
Factors influencing adherence were then classified into 
three domains: patient, health system and provider-related 
factors. 
3. Literature Review 
Factors Affecting Antihypertensive Treatment 
Adherence  
To understand the reasons for low adherence to 
antihypertensive treatments among hypertensive patients,  
various factors are classified in this paper as patient, health 
system and provider related factors. 
3.1. Patient-Related Factors  
According to the literature, individual factors affecting 
antihypertensive treatment adherence include socio-demogr
aphic factors, individual's knowledge and skills, personal 
beliefs and perceptions, and physical and mental ab ility of 
hypertensive patients.  
Socio-demographic Factors 
Numerous studies have investigated the association 
between hypertensive patients’ socio-demographic factors 
and their adherence to treatment regimens. For example, 
older patients report high adherence to antihypertensive 
regimens and better knowledge of their condition than 
younger patients[6]. Interestingly, it  was also found that 
males are more adherent than females but are less consistent 
in taking medication[7]. One study found that females from 
poor socio-economic status and with low educational level 
were more likely to have low antihypertensive treatment 
adherence. Males with a similarly low level of education 
who were also from the same socio-economic class had 
higher antihypertensive treatment adherence[8]. The 
interpretation of this result is that less educated females in 
lower classes are more liable to devote their time to their 
families instead of taking care of themselves. No similar 
study conductedin investigating the role of 
socio-demographic factors in relation to patients’ adherence 
to antihypertensive treatments in Saudi Arabia.  
Individual’s Knowledge and Skills 
There is positive relationship between patient’s levels of 
knowledge of treatment and better adherence[9]. It was 
found that 43.7% of patients believe that antihypertensive 
drugs can be stopped once the blood pressure has stabilized. 
This shows how the lack o f knowledge about treatment 
contributes to patient low adherence behaviour. Patients 
cannot necessarily be blamed for this as studies[9-11] have 
shown that patients’ poor knowledge about medication is 
often related to the effectiveness of the health education they 
receive.  
Some research in Saudi Arab ia has been conducted to 
study the adherence practices of hypertension patients. These 
studies aimed to investigate patients’ adherence and 
knowledge of hypertension[12], patients’ treatment 
practices[13] and hypertension control[14]. The key findings 
included lack o f patients’ knowledge about hypertension[12], 
patients’ hypertension practices need to change by improving 
their diet  and life style to enhance their quality of life[15], 
low awareness of hypertension and also poor control of 
blood pressure and the use of its treatment[14]. Despite this, 
the main strength of these studies is that they were conducted 
using large sample size. The limitation of these studies is the 
data collection methods employed. For example, a study has 
investigated hypertensive patients practice by using the 
WHO stepwise approach to surveillance (STEPS) of no 
communicab le disease risk factors[13]. However, the 
contents of this survey were created to be used to collect 
country-wide informat ion about chronic disease risk factors 
rather than focusing on particular patients’ practices[16]. 
Therefore, fu rther research is required in this area using a 
specifically designed tool to explore Saudi hypertensive 
patients’ adherence behaviour. 
Individual’s Beliefs and Perceptions 
Patients' adherence to treatment often improves when they 
have positive beliefs about the efficacy of the treatment the 
take and trust that their treatment is working well to control 
their illness[17, 18]. However, believing that treatments are 
not important or harmfu l is a barrier to adherence[19]. 
Patients’ beliefs about medical management and drugs in 
particular are driven by their knowledge. For example, some 
hypertensive patients hold the belief that taking 
antihypertensive treatments will result in side effects[12]. 
Cultural background also influences patients’ beliefs about 
medication. A study of Chinese immigrants with 
hypertension living in the United States of America found 
they are lower adherent to antihypertensive treatments. In 
this case adherence is influenced by the perceived benefits of 
Chinese herbs in controlling patients’ blood pressure, and 
western medications for hypertension were shown to be 
perceived as less beneficial[20]. Some religious beliefs 
contribute to patient practices regarding taking medicat ions. 
For example, the Islamic faith supports the notion of taking 
what is beneficial for health to prevent harm and Muslim 
patients therefore take medicat ion to manage and overcome 
illness. However, some Muslims from low socioeconomic 
backgrounds with a poor level o f education might 
misunderstand this relig ious concept. This is the case for 
participants in a study conducted by Griffith and colleagues 
who stated that they were non-adherent to antihypertensive 
treatments among Muslims Bangladeshi patients because of 
the belief that their illness is predetermined from God (Allah) 
and therefore they are not required to intervene with 
treatment[21]. 
Physical and Mental Ability 
Studies that address the role of physical and mental 
abilities and how they influence treatment adherence are rare. 
Physical, mental and sensory abilities, such as auditory or 
visual impairments, can have a negative impact on 
adherence[22]. One physical factor that can affect treatment 
adherence relates to the presence of co-morbid ities. Patients 
with multiple health conditions receive different types of 
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therapies. However, it was found that an increase in the 
number of drugs being taken is not associated with poor 
adherence to antihypertensive treatments in one of the 
studies[23]. This is because patients with co-morbidity who 
receive mult iple medications consider the seriousness of 
their health condition[23]. 
Psychological impairment also influences poor health 
outcomes[24]. Psychological conditions such as stress, fear 
and anxiety are linked to poor treatment adherence[25]. This 
is because patients experiencing these conditions are often 
unable to properly manage their conditions. In addition, the 
risk of low adherence to antihypertensive treatment is higher 
among patients who feel ashamed, guilty and dissatisfied 
regarding their non-adherence[25]. On  the contrary, patients 
who are aware of the negative impact of stress show better 
adherence to antihypertensive medications[26], which 
supports the significant ro le of knowledge in treatment 
adherence[9]. 
3.2. Health System Related Factors 
The quality of the healthcare system is also an important 
factor that can help or hinder patients’ adherence to 
treatments. In terms of hypertension management, the 
healthcare system is inclusive of policies, resources, and 
financial arrangements that determine the quality of medical 
services, for example, physician skills.  
Guidelines for Management and Policy  
Hypertension guidelines consist of standardised 
informat ion developed to enable healthcare practit ioners to 
provide the best practices in terms of prevention, early 
detection and management of hypertension. All existing 
guidelines for hypertension management derived from WHO 
international recommendations and recent evidence-based 
research emphasise high quality of care[1]. 
Various hypertension management guidelines have been 
devised and distributed worldwide in order to improve the 
control of hypertension. Recommendations concerning 
screening, diagnosis and treatment of hypertension are 
contained in these guidelines. Fo llowing ev idence from 
clin ical trials, the guidelines for management of 
hypertension recommend certain classes of drugs for 
treating hypertension with and without co-morbid ities. 
These drugs serve as the baseline in daily medical care 
when assessing the quality of pharmacotherapy[27]. 
A number of studies have investigated the quality of 
hypertension management in Saudi Arabia. These studies 
considered physician adherence to the hypertension 
management guidelines[28] and the quality of hypertension 
management in primary care settings[29]. Valuable findings 
include deficiencies in physicians’ practices, poor 
hypertension control and the absence of an electronic patient 
record system revealed. Howeverresults from these studies 
are questionable they were local and evaluated only one 
primary healthcare centre[29] or were limited by a small 
sample size[30].  
Barriers identified for physicians not adhering to the 
clin ical guidelines are classified into three themes that 
include physicians' knowledge (lack of awareness, 
familiarity), attitudes (disagreement, outcome expectancy or 
lack of act ivity) or physicians' behaviour.  Barriers present 
in one setting may not be present in another, therefore 
assessing these in different settings barriers is important in 
improving adherence to guidelines[31]. 
Quality of Healthcare Services  
The quality of the healthcare system plays a role in  
patients’ adherence practices. For example, the availab ility 
of a well-established system of keeping patient records is 
critical in  tracking adherence[32]. Record ing information 
about patients’ regular follow-ups, current condition, the 
frequency of medication refills and the date of the last refill 
all are important in tracking  patients’ adherence and 
therefore in preventing complications via in itiating suitable 
interventions for low adherent patients[32]. A cross-sectional 
study in Saudi Arabia that aimed to identify the management 
practices of hypertensive patients by evaluating patients’ 
records showed poor recording o f informat ion, such as 
smoking status, any family  history of cardiovascular disease 
and patients’ body mass index (BMI). The study findings 
show that only a quarter of the 201 hypertension cases 
studied were sufficiently controlled[30]. Another study 
evaluated 120 patients’ records from two healthcare centres 
in Saudi Arabia based on the Quality Assurance Guideline 
introduced by the Saudi Ministry of Health. The data 
revealed that 63% of hypertensive cases were well controlled, 
50% had good compliance with appointments and only 9% 
suffered from hypertension-related complications[33]. The 
most important finding was that providers’ hypertension 
management practices are not in accordance with the 
recommended national standard of care. Providing higher 
quality of care is associated with better hypertension control 
and the prevention of complications[34].  
Cost of Treatment 
The costs of medications have an inverse relationship with 
treatment adherence. It was reported that higher medication 
costs result in lower overall healthcare costs that in turn 
result from increased use of more expensive medicat ions to 
treat chronic conditions, such as hypertension, diabetes 
mellitus, hypercholesterolemia and heart failure[35]. 
Cost-related issues consider as a possible reason for 
patients failing to respond to pharmacotherapy. In cases 
whereby the patient’s health does not improve due to the 
underuse of medication because of its cost, a common 
response of a physician is to increase their dosage, or add 
augmentation therapy, which is unlikely to improve 
outcomes[36]. Physicians should be familiar with the costs 
of drugs for their patients. One study found that costs 
increased in cases where the guidelines were not adhered to. 
This finding suggests that more expensive drugs were 
prescribed instead of cheaper drugs, such as diuretics, as a 
first line treatment[37]. 
Prices of antihypertensive medicat ions in Saudi Arabia 
are affordable and range from 1 US$ and ≤ 30 
US$ according to the published Saudi Hypertension 
Management Guidelines that provided the list of the 
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available oral antihypertensive agents in Saudi Arabia and 
the pricing list for these drugs[38]. However, most residents 
of Saudi Arabia (and the Gulf region in general) receive free 
health care. Prescription medication from governmental 
hospitals and primary health care clin ics is also provided at 
no cost[39, 40]. Community pharmacies are also availab le 
and provide drug products available for purchase for 
households to supplement their medication  requirements. 
There are >3000 community pharmacies in Saudi Arab ia 
alone. The majority of these pharmacies are located in the 
regions of Riyadh and Jeddah[40]. 
However, with this privilege of receiving free cost 
therapy, patients' adherence behaviour in relat ion to free 
drug cost is unknown, and the assumption should not solely 
hypothesise that free drug cost is associated with  increasing 
patients’ adherence, because the adherence practice is 
influenced by different contextual factors other than drug 
price. 
Patient Resources 
Patient resources are those provided by the healthcare 
system to enhance patients’ treatment practices, for example, 
written patient education materials and patient education 
sessions. Compared to no active intervention, the effect of 
printed educational materials appears to be minor and the 
clin ical significance is uncertain[41]. The outcome of 
providing patient resources is increased patient knowledge 
and support. An integrated and community-based comprehe
nsive intervention programme for health promotion and 
non-communicable disease prevention was successful in the 
United Arab Emirates (UAE) for dealing with diseases that 
were d iet related. The programme addressed primary, 
secondary and tertiary prevention levels[42]. 
In Saudi Arabia a study conducted in 15 primary  health 
care centres in Al-Qassim province in 2009 showed that 
health education interventions were successful in making 
changes in the lifestyle of chronic patients[43].  
3.3. Provider Related Factors  
According to the available studies, provider related factors 
in relation to antihypertensive medication adherence include 
provider-patient relationship and communicat ion. No studies 
conducted in Saudi Arabia were found reporting on the 
influence of provider-patient relationship or communication 
in relation to antihypertensive medication adherence. 
Provider-patient relationship 
The quality of the therapeutic relat ionship between 
patients and healthcare providers defined in terms of the 
level of satisfaction and degree of autonomy patients 
experience when they deal with healthcare providers[44]. 
Patient satisfaction concerning the healthcare provided to 
them is an indication of a good patient-physician 
relationship. Researchers have found that the level of 
patients’ satisfaction has a positive effect on their adherence 
to taking the requisite medication; however satisfaction 
level is difficult to be measured[45-47].  Patients who are 
unsatisfied with their relationships with their healthcare 
providers may perceive that the healthcare environment is 
not therapeutic. Th is may then result in lower levels of 
adherence to taking the requisite medication due to a lack of 
patient empowerment[48]. 
Provider-Patient Communication 
Interestingly, there is a large volume of published studies 
describing the role of physician-patient communication in 
enhancing patients’ adherence to medication[48-50]. The 
outcome of ‘patient-centred’ communication between 
patients and health care providers is that it contributes to 
increase patients’ understanding about their illnesses and 
adherence to treatments. This based on the provided support 
from health care providers. 
Although the interpersonal communicat ion process in the 
patient-physician relationship has a potentially positive 
impact on patients’ health outcomes, physicians usually do 
not ask their patients about medication-taking behaviour or 
may use ineffective communication approaches[49]. It  is 
argued that non-collaborative communication on the part of 
healthcare providers result in poor patient adherence to 
antihypertensive treatments[50]. In  Saudi Arabia, attention 
has been drawn towards enhancing healthcare team 
communicat ion skills in o rder to improve patients’ health 
outcomes. The impact of enhanced health education 
programs about health knowledge and behaviour (lifestyle 
modification) of patients with chronic conditions provided 
valuable results in improving patients’ adherence to taking 
medication[43].  
4. Conclusions 
This paper has reviewed and critically analysed different 
factors of hypertensive patients’ adherence to 
antihypertensive treatmentswhich include factors related to 
hypertensive patients themselves (e.g. sociodemographic 
factors, individuals knowledge and skills), health system 
related factors (such as treatment cost and patients 
resources), and provider related factors (such as the 
relationship with patients and communication).  
The available studies in Saudi Arabia show that 
hypertensive patients report insufficient knowledge about 
hypertension and its management, and low hypertension 
control. In  addition physicians report low adherence to 
hypertension management guidelines. Further research is 
required investigating Saudi hypertensive patients’ 
adherence behaviour, and the influence of patient, health 
system and providerrelated factors on antihypertensive 
treatment adherence among this population.  
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